TOP

LOGIN
Products
Products
Products
You are viewing the International version of this page; click here for other versions.
Products Services Knowledge

At Gen Re, we believe that information and collaboration are the basis for great innovation.

We leverage the actuarial, medical, and underwriting expertise of our global units with the market-specific knowledge of our regional departments to support your product initiatives.

Our product development support comprises a wide range of services needed by primary insurers, including design of new products, calculation of the respective rates, and development of policy terms and conditions. Post-launch, our portfolio monitoring and experience studies offer additional valuable insights.

Our Products

Card Image

Mortality

Card Image

Longevity

Card Image

Disability

Card Image

Critical Illness/
Dread Disease

Card Image

Health

Card Image

Long Term Care

Our Services

Underwriting

Risk assessment of individual lives is a core strength at Gen Re. We offer services in all areas of risk assessment.

Learn More

Market Research & Surveys

Understand biometric risks – from single portfolios to market-wide surveys.

Learn More

Analytics

Using a wide range of techniques such as random forest, GLMs or neural networks our data scientists get the most of complex data; always in collaborations with our experts from other fields a maximum of insights and interpretability is achieved.

Learn More

Digital Solutions

We help our clients create digital solutions across the insurance value chain.

Learn More

Recent Research

Publication
Understanding Breast Cancer in Asia – Awareness and the Importance of Screening
Breast cancer ranks as the most prevalent cancer worldwide, and a staggering 2.3 million women were diagnosed with the illness globally in 2020. Although the prospects of survival in the battle against breast cancer are improving, the financial burden on patients remains significant. CI benefits can assist with managing the expenses.
Wendy Low, Pei Nee Yong, Samuel Lim October 19, 2023
Read More
Publication
Microdosing – The Underwriting Perspective
A growing body of scientific evidence suggests a positive relationship between microdosing psychedelic drugs and an improvement of mental disorders such as depression. We explore which drugs are commonly used for microdosing, how they work and the potential benefits and challenges they present.
Annika Luckmann February 18, 2025
Read More
Publication
Chronic Pain and the Role of Insurers – A Multifactorial Perspective on Causes, Therapies and Prognosis
Chronic pain needs a comprehensive approach, considering biological, psychological, and social factors. Emerging technologies like VR, gene therapy, and stem cell interventions show promise. Personalized care and early intervention can improve outcomes and reduce costs. Collaboration among stakeholders is essential to mitigate chronic pain’s impact.
Dr. Sebastian Speicher February 13, 2025
Read More
Publication
Screening Tests and Insurers – Lessons From PSA Testing in Asymptomatic Men
PSA screening for prostate cancer presents key considerations for insurers. While it aids early detection, concerns about overdiagnosis highlight the need for careful evaluation. Insurers must balance screening requirements with ethical implications, ensuring tests are conducted appropriately.
Dr. Chris Ball February 04, 2025
Read More
Publication
When Actuaries Meet Claims Managers – Data-Driven Disability Claims Review
The Gen Re 3D Tool calculates prio scores for Income Protection claims portfolios based on the probability of recovery and the present value of benefits. This can support claims assessors in deciding which cases are particularly suitable for a review.
Dr. Andreas Heider December 18, 2024
Read More

Find an Expert in Your Region